Medicare Drug Plan Comparison Tool Helps Seniors Save
Medicare Open Enrollment currently underway allows millions of Medicare beneficiaries to find the best drug plan coverage for the coming year. According to Jesse Slome, director of the Medicare-focused organization, a majority of seniors do not take advantage of the opportunity to review and lock in a potentially better plan for the coming year.
"Prescription drug plans typically change each January and those changes can mean you'll pay more in 2023," says Slome. "Medicare mandates that plans give you the chance to review changes and, if you want, find a drug plan that will save you money, get better coverage or both."
Those who take advantage of the opportunity can easily save significant dollars in 2023, the Association director notes. The organization reports that average savings among those who switched plans last year amounted to between $500 and $700.
The American Association for Medicare Supplement Insurance makes available access to a free online drug plan comparison tool. "Consumers do not have to enter any personal information other than their Zip Code to use the tool," Slome adds. "It's completely private and compares over 4,700 plans to find the best one in your area."
Access to the Medicare drug plan comparison tool can be accessed on the Association's website at https://www.medicaresupp.org/best-medicare-drug-plans-2023/.
Slome advises that entering information on the various prescription drugs you take will yield the best 2023 price comparison.
32504 Carrie Place
Westlake Village, CA 91361
Established in 1998, the American Association for Medicare Supplement Insurance advocates for the importance of consumer awareness and supports insurance and financial professionals who market Medicare insurance solutions. Visit their website for more information at https://medicaresupp.org.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Medicare Drug Plan Comparison Tool Helps Seniors Save here
News-ID: 2776470 • Views: 207
More Releases from American Association for Medicare Supplement Insurance
Lowest Available Medicare Medigap Plan G Rates Reported
A woman turning 65 in Iowa can purchase a comprehensive Medigap insurance plan for $79-per month. If she lives in New York City, comparable coverage costs $278 according to a report just published by the American Association for Medicare Supplement Insurance (AAMSI). "Medicare is a national program but Medicare plan options are local," explains Jesse Slome, director of the organization. AAMSI has just published the 2023 Medigap Price Index for Plan
Medicare Open Enrollment Ends In One Week
The opportunity for millions of Americans to switch Medicare plans ends in a week on December 7th according to the American Association for Medicare Supplement Insurance (AAMSI). "Once a year Medicare gives Americans an opportunity to compare their current plan and freely switch to a plan that will offer better coverage for 2023," explains Jesse Slome, director of the Medicare-focused organization. A recent study from the organization found that many fail
Medicare Insurance Agent Online Directory Prepares For Annual Enrollment
Millions of Americans will take advantage of the upcoming Medicare Annual Enrollment Period (AEP) to find better Medicare coverage. "Medicare plan sellers are spending millions of dollars on television ads featuring celebrities but they are not necessarily directing seniors to the best plan choices," says Jesse Slome, director of the American Association for Medicare Supplement Insurance. According to Slome, the Centers for Medicare and Medicaid Services (CMS) reported receiving so many
Medicare Insurance Agents Offered Public Relations Toolkit
The American Association for Medicare Supplement Insurance announced plans to make available the 2022 Medicare Agent Publicity Toolkit for agents marketing Medicare insurance solutions. "It's getting downright impossible for independent Medicare agents and brokers to compete with the millions of dollars spent on celebrity spokespeople promoting Medicare solutions," declares Jesse Slome, director of the Association. "We believe future success for many agents will depend on their ability to dominate their
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market. Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug